162 related articles for article (PubMed ID: 31966437)
1. Low expression of miRNA-1290 associated with local invasion and recurrence in sacral chordoma.
Wang Y; Chen K; Chen H; Zhang K; Lu J; Mao H; Yang H
Int J Clin Exp Pathol; 2017; 10(11):10934-10940. PubMed ID: 31966437
[TBL] [Abstract][Full Text] [Related]
2. High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis.
Zhang K; Chen H; Wu G; Chen K; Yang H
Med Oncol; 2014 Nov; 31(11):247. PubMed ID: 25260803
[TBL] [Abstract][Full Text] [Related]
3. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
[TBL] [Abstract][Full Text] [Related]
4. Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.
Chen K; Mo J; Zhou M; Wang G; Wu G; Chen H; Zhang K; Yang H
Med Oncol; 2014 Apr; 31(4):886. PubMed ID: 24535608
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.
Zhou M; Chen K; Yang H; Wang G; Lu J; Ji Y; Wu C; Chen C
J Neurooncol; 2014 Jan; 116(1):77-82. PubMed ID: 24135846
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma.
Chen K; Chen H; Zhang K; Sun S; Mo J; Lu J; Qian Z; Yang H
Oncol Lett; 2017 Nov; 14(5):5533-5539. PubMed ID: 29113181
[TBL] [Abstract][Full Text] [Related]
10. Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.
Zou MX; Lv GH; Li J; She XL; Jiang Y
Am J Transl Res; 2016; 8(2):516-29. PubMed ID: 27158344
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma.
Huang W; Yan YG; Wang WJ; Ouyang ZH; Li XL; Zhang TL; Wang XB; Wang B; Lv GH; Li J; Zou MX
Front Oncol; 2020; 10():556902. PubMed ID: 33194623
[TBL] [Abstract][Full Text] [Related]
12. Potential molecular mechanism in self-renewal is associated with miRNA dysregulation in sacral chordoma - A next-generation RNA sequencing study.
Bozsodi A; Scholtz B; Papp G; Sapi Z; Biczo A; Varga PP; Lazary A
Heliyon; 2022 Aug; 8(8):e10227. PubMed ID: 36033338
[TBL] [Abstract][Full Text] [Related]
13. PARP1 is a novel independent prognostic factor for the poor prognosis of chordoma.
Li Z; Lv T; Liu Y; Huang X; Qiu Z; Li J
Cancer Biomark; 2016 Mar; 16(4):633-9. PubMed ID: 27002766
[TBL] [Abstract][Full Text] [Related]
14. miR-1290 inhibits chordoma cell proliferation and invasion by targeting Robo1.
Wang B; Zhang K; Chen H; Lu J; Wu G; Yang H; Chen K
Transl Cancer Res; 2019 Apr; 8(2):542-551. PubMed ID: 35116786
[TBL] [Abstract][Full Text] [Related]
15. Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma.
Wei J; Wu J; Yin Z; Li X; Liu Y; Wang Y; Wang Z; Xu C; Fan L
Front Oncol; 2022; 12():1048482. PubMed ID: 36601478
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression.
Duan Z; Choy E; Nielsen GP; Rosenberg A; Iafrate J; Yang C; Schwab J; Mankin H; Xavier R; Hornicek FJ
J Orthop Res; 2010 Jun; 28(6):746-52. PubMed ID: 20041488
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155 expression is independently predictive of outcome in chordoma.
Osaka E; Kelly AD; Spentzos D; Choy E; Yang X; Shen JK; Yang P; Mankin HJ; Hornicek FJ; Duan Z
Oncotarget; 2015 Apr; 6(11):9125-39. PubMed ID: 25823817
[TBL] [Abstract][Full Text] [Related]
18. Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis.
Wen H; Ma H; Li P; Zheng J; Yu Y; Lv G
Biochem Biophys Res Commun; 2017 Sep; 491(4):1047-1054. PubMed ID: 28780352
[TBL] [Abstract][Full Text] [Related]
19. ADAM10 Is a Potential Novel Prognostic Biomarker for Sacral Chordoma.
Ding Y; Bui MM; Wang Q; Sun X; Zhang M; Niu X; Tian W
Ann Clin Lab Sci; 2019 May; 49(3):309-316. PubMed ID: 31308029
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NONHSAT114552 Sponges miR-320d to Promote Proliferation and Invasion of Chordoma Through Upregulating NRP1.
Zhang K; Liu Z; Tang Y; Shao X; Hua X; Liu H; Yang H; Chen K
Front Pharmacol; 2021; 12():773918. PubMed ID: 34721048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
